These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7054319)

  • 1. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
    Reid JH; Patrick S
    J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Bacteroides asaccharolyticus cells and B. fragilis surface components on serum opsonisation and phagocytosis.
    Jones GR; Gemmell CG
    J Med Microbiol; 1986 Nov; 22(3):225-9. PubMed ID: 3534273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes.
    Bjornson AB; Bjornson HS; Kitko BP
    Infect Immun; 1980 May; 28(2):633-7. PubMed ID: 7399680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
    Wade BH; Kasper DL; Mandell GL
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.
    Connolly JC; McLean C; Tabaqchali S
    J Med Microbiol; 1984 Jun; 17(3):259-71. PubMed ID: 6374150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal model system for studying virulence of and host response to Bacteroides fragilis.
    Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
    Bjornson AB; Bjornson HS; Kitko BP
    Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
    Kasper DL
    J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of humoral factors in host resistance to the Bacteroides fragilis group.
    Bjornson AB
    Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.
    Gemmell CG; Peterson PK; Schmeling D; Mathews J; Quie PG
    Eur J Clin Microbiol; 1983 Aug; 2(4):327-34. PubMed ID: 6628373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R; Gupta U; Watanabe K; Ueno K
    Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial killing in vitro by abscess-derived neutrophils.
    Finlay-Jones JJ; Hart PH; Spencer LK; Nulsen MF; Kenny PA; McDonald PJ
    J Med Microbiol; 1991 Feb; 34(2):73-81. PubMed ID: 1990143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic synergy: mixed intra-abdominal infections.
    MacLaren DM; Namavar F; Verweij-Van Vught AM; Vel WA; Kaan JA
    Antonie Van Leeuwenhoek; 1984; 50(5-6):775-87. PubMed ID: 6397140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1986 Apr; 39(4):376-82. PubMed ID: 3517072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.